← Back
$TRDA All transactions

Entrada Therapeutics, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$367K

Shares

25,000

Price

$15

Filed

Jun 18

Why this score? (8/10)
  • Open market buy (+3)
  • Trade value >= $250K (+1)
  • % of holdings >= 20% (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

KIM PETER S

Title

CIK

0001181180

Roles

Director

Transaction Details

Transaction Date

2024-05-13

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

92,412

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.63 to $14.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | On May 16, 2024, the Reporting Person filed a Form 4 that reported the purchase of 25,000 shares of common stock on May 14, 2024 and inadvertently omitted to report the purchase of an additional 25,000 shares of common stock on May 13, 2024. This Form 4/A reports the purchase of those 25,000 additional shares of common stock and to correct certain totals. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.465 to $14.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001689375-25-000035

Form Type

4/A

Issuer CIK

0001689375

KIM PETER S's History

Date Ticker Type Value
2025-06-11 TRDA A $0
2024-05-14 TRDA $365K
2024-05-13 TRDA $367K

Other Insiders at TRDA (90d)

Insider Bought Sold Last
WENTWORTH KORY JAMES
Chief Financial Officer
$32K 2026-04-01